ARDENT HEALTH INC (ARDT) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:ARDT - US03980N1072 - Common Stock
8.79 USD
-0.08 (-0.9%)
8.741 USD
-0.05 (-0.56%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.13B 5.32% | 5.409B 5.45% | 5.966B 10.29% | 6.472B 8.48% | 6.792B 4.94% | 7.188B 5.83% | 7.862B 9.38% | |
| EBITDA YoY % growth | 338.426M -23.15% | 356.685M 5.40% | 552.05M 54.77% | 607.74M 10.09% | 648.44M 6.70% | 705.35M 8.78% | N/A | |
| EBIT YoY % growth | 200.253M -33.95% | 215.843M 7.79% | 405.762M 87.99% | 501.35M 23.56% | 541.23M 7.95% | 574.58M 6.16% | N/A | |
| Operating Margin | 3.90% | 3.99% | 6.80% | 7.75% | 7.97% | 7.99% | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | 1.88 52.55% | 1.95 4.10% | 2.21 13.28% | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.43 -46.61% | 0.21 -27.02% | 0.38 -26.44% | 0.26 -49.98% | 0.66 53.30% | 0.40 90.36% | 0.59 53.33% | 0.45 72.55% | 0.79 18.46% |
| Revenue Q2Q % growth | 1.657B 3.16% | 1.612B 7.67% | 1.695B 3.02% | 1.669B 5.85% | 1.811B 9.29% | 1.698B 5.33% | 1.833B 8.14% | 1.716B 2.82% | 1.92B 6.02% |
| EBITDA Q2Q % growth | 134.02M -55.89% | 109.44M 5.95% | 147.13M -30.86% | 123.49M -5.82% | 201.23M 50.15% | 123.42M 12.77% | 197.88M 34.49% | 172.38M 39.59% | 211.14M 4.92% |
| EBIT Q2Q % growth | 97.734M -37.98% | 72.595M 8.20% | 112.65M -17.94% | 90.898M 452.30% | 176.32M 80.41% | 160.09M 120.52% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.52 205.88% | 0.42 | 0.10 | 24.85% |
| Q2 2025 Q2Q % growth | 0.52 52.94% | 0.30 | 0.22 | 71.20% |
| Q1 2025 Q2Q % growth | 0.29 | 0.20 | 0.09 | 43.05% |
| Q4 2024 Q2Q % growth | 0.81 | 0.46 | 0.35 | 76.20% |
| Q3 2024 Q2Q % growth | 0.17 | 0.31 | -0.14 | -44.28% |
| Q2 2024 Q2Q % growth | 0.34 | 0.31 | 0.03 | 10.01% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.577B 8.75% | 1.578B | -1.254M | -0.08% |
| Q2 2025 Q2Q % growth | 1.645B 11.85% | 1.577B | 68.28M | 4.33% |
| Q1 2025 Q2Q % growth | 1.497B 4.04% | 1.528B | -30.766M | -2.01% |
| Q4 2024 Q2Q % growth | 1.606B | 1.514B | 92.289M | 6.10% |
| Q3 2024 Q2Q % growth | 1.45B | 1.481B | -31.183M | -2.11% |
| Q2 2024 Q2Q % growth | 1.471B | 1.487B | -16.08M | -1.08% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -33.4% | -33.33% | 0% | 0.19% |
| Revenue | -1.95% | -2.01% | 0% | -0.03% |